Roberto Mina, Cyrille Touzeau, Vania Hungria, Carl Ola Landgren, Divaya Bhutani, Wenming Chen, Swarup Kumar, Chakra Pani Chaulagain, Meletios A. Dimopoulos, Nizar Jacques J. Bahlis, Senem Maral, Niels W.C.J. van de Donk, Khalid Saja, Raphael Teipel, Miki Ando, Dai Wang, Susan Wroblewski, Priya Shah, Katherine Chastain, Hang Quach. "MajesTEC-9: A phase 3 randomized study of teclistamab monotherapy vs investigator’s choice of pomalidomide, bortezomib, and dexamethasone or carfilzomib and dexamethasone (PVd/Kd) in patients (pts) with relapsed refractory multiple myeloma (RRMM).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7507